by Mosquito-borne diseases affect millions of people worldwide each year, with malaria being the most prevalent. Symptoms of mosquito-borne illnesses vary depending on the disease, but may include fever, headache, pains, and skin rashes. Prevention strategies focus on reducing exposure to mosquito bites through use of nets, insect repellents, and reducing areas where mosquitoes breed. Major mosquito-borne diseases include malaria, dengue, chikungunya, Zika, yellow fever, and West Nile virus. Malaria alone caused approximately 627,000 deaths in 2020.
The global Mosquito Borne Disease Market is estimated to be valued at Us$ 3.11 Bn in 2023 and is expected to exhibit a CAGR Of 6.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Rising prevalence of mosquito-borne diseases due to factors like rapid urbanization, migration, globalization, and climate change are expected to drive the market growth over the forecast period. According to WHO, in 2020, there were 241 million cases of malaria globally. Dengue cases have also increased 30-fold over the past few decades, putting almost half of the world’s population at risk. The increasing spread of these diseases is prompting government bodies and non-profit organizations worldwide to invest in prevention and treatment measures including vaccines, diagnostic tests, and drugs. This is fueling the demand for mosquito borne disease management and thereby propelling the market growth. Furthermore, rising awareness among people about symptoms and preventive measures for mosquito-borne illnesses is also contributing to the market expansion.
Segment Analysis
The mosquito borne disease market can be segmented by type into malaria, zika virus, chikungunya, dengue, yellow fever, and others. The malaria segment is dominating the market presently with around 90% share due to the high prevalence of malaria worldwide, especially in developing regions of Africa, South East Asia and Latin America. Malaria causes the highest disease burden in terms of mortality and morbidity among all mosquito borne diseases globally.
PEST Analysis
Political: Governments of various countries have launched several initiatives and awareness programs to prevent mosquito borne diseases. For example, the national vector borne disease control program in India.
Economic: The outbreak of mosquito borne diseases negatively impacts the economy due to rise in healthcare costs and loss of productivity. However, continuous R&D activities by companies for development of diagnostics, vaccines and drugs is boosting the market growth.
Social: Social determinants like poverty, lack of access to healthcare, illiteracy and lack of awareness in rural areas increases the risk and spread of these diseases.
Technological: Advancements in vector control strategies like use of genetically modified mosquitoes and larviciding are helping limit the spread of these diseases. Development of novel treatment options is also aiding the market.
Key Takeaways
The Global Mosquito Borne Disease Market Demand is expected to witness high growth over the forecast period. Regionally, Asia Pacific accounts for over 60% market share and is the fastest growing market due to the large population affected by dengue, malaria and chikungunya in countries like India and Indonesia.
Key players operating in the mosquito borne disease market are Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc. Key players are undertaking various collaborations and new product launches to consolidate their market position. For instance, in 2022, GSK announced positive results from the phase 3 trial of its RTS,S/AS01E malaria vaccine candidate.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
